Skip to structure collection
Browse lipid products ↗
Home  /  Research resources  /  Patent lipid structures
A structure-first resource for LNP research

WO2013086322A1 — Lipid Structures

Explore 29 lipid entries associated with patent publication WO2013086322A1 in this collection. View structures, source annotations and a direct link to the patent document.

Company / institution labels in this source: ALNYLAM PHARMACEUTICALS INC. Read the original patent publication ↗

5,635Distinct structures
155Patent publications
14Source classifications
8,673Source records retained
More filters: linker type, publication year & molecular weight
29 entries

Click a structure to browse its details, source annotations and patent provenance. Patent and property information is reproduced from the collected records.

EtherWO2013086322A1
Chemical structure for CAS 1443113-91-4

CAS 1443113-91-4

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC35H69NO5
MW · source (g/mol)583.93
View patent ↗
EtherWO2013086322A1
Chemical structure for 10-[4-(Dimethylamino)butoxy]-1,19-nonadecanediol

10-[4-(Dimethylamino)butoxy]-1,19-nonadecanediol

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC25H53NO3
MW · source (g/mol)415.69
View patent ↗
EtherWO2013086322A1
Chemical structure for CAS 1443113-74-3

CAS 1443113-74-3

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC41H81NO5
MW · source (g/mol)668.09
View patent ↗
EsterWO2013086322A1
Chemical structure for CAS 1443113-84-5

CAS 1443113-84-5

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC35H67NO6
MW · source (g/mol)597.91
View patent ↗
EsterWO2013086322A1
Chemical structure for CAS 1443113-58-3

CAS 1443113-58-3

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC41H75NO6
MW · source (g/mol)678.04
View patent ↗
EsterWO2013086322A1
Chemical structure for CAS 1443113-54-9

CAS 1443113-54-9

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC39H71NO6
MW · source (g/mol)649.99
View patent ↗
EsterWO2013086322A1
Chemical structure for CAS 1443113-56-1

CAS 1443113-56-1

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC37H67NO6
MW · source (g/mol)621.93
View patent ↗
EsterWO2013086322A1
Chemical structure for CAS 1443113-62-9

CAS 1443113-62-9

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC41H75NO6
MW · source (g/mol)678.04
View patent ↗
EsterWO2013086322A1
Chemical structure for 1,19-Dicyclopentyl 10-[4-(dimethylamino)-1-oxobutoxy]nonadecanedioate

1,19-Dicyclopentyl 10-[4-(dimethylamino)-1-oxobutoxy]nonadecanedioate

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC35H63NO6
MW · source (g/mol)593.88
View patent ↗
EsterWO2013086322A1
Chemical structure for CAS 1443113-65-2

CAS 1443113-65-2

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC45H79NO6
MW · source (g/mol)730.11
View patent ↗
EsterWO2013086322A1
Chemical structure for 1,25-Dihexyl 13-[4-(dimethylamino)-1-oxobutoxy]pentacosanedioate

1,25-Dihexyl 13-[4-(dimethylamino)-1-oxobutoxy]pentacosanedioate

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC43H83NO6
MW · source (g/mol)710.12
View patent ↗
EsterWO2013086322A1
Chemical structure for 1,13-Diundecyl 7-[4-(dimethylamino)-1-oxobutoxy]tridecanedioate

1,13-Diundecyl 7-[4-(dimethylamino)-1-oxobutoxy]tridecanedioate

ALNYLAM PHARMACEUTICALS INC
Molecular formulaC41H79NO6
MW · source (g/mol)682.07
View patent ↗
Explore the chemistry. Trace the source.

A reference collection for lipid design

This collection brings together patent-associated lipid structures for researchers exploring LNP chemistry. Browse molecular structures alongside CAS numbers, molecular formulas, molecular weights, company and institution labels, patent identifiers, source years, and linker annotations. Each entry links to its listed patent publication.

The 8,673 source rows have been consolidated into 5,637 entries representing 5,635 distinct structures. Identical rows appearing in several worksheets are grouped, with every worksheet and row location retained. Structure diagrams are generated from the supplied SMILES, preserving stated stereochemistry and disconnected components. Names, classifications, company labels and year fields reflect the source collection; consult the linked patent document for its original bibliographic information. This is a collected reference set, not an exhaustive or current census of all lipid patents.

Browse the 1 patent publications in this view

Structure details